TPI [TIANYIN PHARMACEUTICAL] UPLOAD: (Original Filing)
[]
[£ £ £ £ Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. In accordance with NYSE procedures, the Company has six months from the receipt of the notice on March 30, 2012 to cure this deficiency. The Company can regain compliance at any time during the six-month cure period if]
[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong Chief Executive Officer Secretary EX-3.1 2 ex3-1.htm] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCK SPLIT -- XIANYANG, China, April 3, 2012 As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 9,398,892. Fractional stockholdings will be rounded up to the nearest whole number. The reverse stock split will affect all stockholders uniformly and will not affect any stockholder’s ownership]
[ARTICLES OF AMENDMENT TO THE ARTICLES OFORPORATION OF BIOSTAR PHARMACEUTICALS, This is to certify that: SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Ronghua Wang Shuang Gong Chief Executive Officer Secretary ex3-1.htm 2 EX-3.1] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCKLIT -- XIANYANG, China, April 3, 2012 a result of the reverse stocklit, the number of outstandingmmon shares will be reduced to approximately 9,398,892.Fractional stockholdings will be rounded up to the nearest whole number.The reverse stocklit will affectl stockholders uniformly and will not affect any stockholders ownership percentage of the]
[The Company's shares trading on NASDAQ was halted on April 3, 2012 at 10:13:42 a.m. Eastern Time by NASDAQ for an “additional information request”, which was subsequently provided by the Company. The trading of the Company’s shares is scheduled to resume on Wednesday, April 4, 2012, at 7:15 a.m. Eastern Time. GLOBAL SOURCES LTD.]
[USIP O C 13G Page 1 of 15 Joint Filing Agreement March This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument. Commonwealth Bank of Australia John Damien Hatton Company Secretary Colonial Holding Company Limited John Damien Hatton Director Commonwealth Insurance Holdings Limited John Damien Hatton Director Colonial First State] [USIP O C 13G Page 1 of 15 Item 7 Information The securities being reported on by the reporting persons herein as parent holding companies are owned, or may be deemed to be beneficially owned as follows: Company Type of Company. First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International Ltd. IA (US registered) First State]
[USIP O C 13G Page 2 of 15 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OFOVE PERSONmmonwealth Bank of Australia * 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australianpital Territory] [USIP O C 13G Page 1 of 15 Joint Filingreement March STYLE="font-family:Times New Roman" SIZE="2"> Thisreement may be executed in multipleunterparts, each of which shallnstitute an original, one and theme instrument.mmonwealth Bank of Australia Johnmien Hattonmpany Secretarylonialmpany Limited Johnmien Hatton] [USIP O C 13G Page 1 of 15 Item7 Information STYLE="font-family:Times New Roman" SIZE="2"> The securities being reported on by the reporting persons herein parentmpanies are owned, or may be deemed to be beneficially owned follows:mpany Type ofmpany. First State Investments (Hong Kong) Limited IA (HK registered)]
[12TH FLOOR EAST TOWER | TWIN TOWERS | B-12 JIANGUOMENWAI DAJIE | BEIJING | 100022 WWW.SHEARMAN.COM | T +86.10.5922.8000 | F +86.10.6563.6000 RESIDENT PARTNERS April 3, 2012 VIA EDGAR Ms. Kathleen Collins, Accounting Branch Chief Ms. Megan Akst Division of Corporation Finance 100 F Street, NE Re: SINA Corporation Form 20-F for the Fiscal Year ended December 31, 2010 Filed]